µ²ºc¦¡ |
|
Atorvastatin [R-(R*, R*)]-2-(4-fluorophenyl)-£], £_-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino) carbonyl]-1H-pyrrole-1-heptanoic acid, calcium salt (2:1) trihydrate
|
UpToDate |
UpToDate ³sµ²
|
ÃIJz§@¥Î |
|
1. ¥»«~¬O3-hydroxy-3methylglutaryl-coenzyme A(HMG-CoA)ÁÙì酶§í¨î¾¯¡C¦¹ºØ»Ã¯À¶Ê¤ÆHMG-CoAÂàÅܬ°mevalonateªºÂà¤Æ¤ÏÀ³¡A¦Ó¸ÓÂà¤Æ¤ÏÀ³¤D¬OÁx©T¾J¥Í¦X¦¨ªº¦´Á¨BÆJ¡A¤]¬O³t²v¨M©w¨BÆJ¡C 2. ¥Î©ó¦P«¬¤Î²§«¬±µ¦X¤l©Ê®a±Ú©Ê°ªÁx©T¾J¦å¯g¡B«D®a±Ú©Ê°ªÁx©T¾J¦å¯g¤Î²V¦X«¬¦å¯×²§±`±wªÌ¡A¥i°§C¨äÁ`Áx©T¾J¡BLDL-Áx©T¾J¤Îapo B¡C¥»«~¤]·|°§CVLDL-Áx©T¾J¤ÎTG¿@«×¡A¨Ã¼W¥[HDL-Áx©T¾J¤ÎapoIipoprotein A-1¿@«×¡C¥Î©ó¹jÂ÷©Ê°ª¤T»Ä¥Ìªoà¦å¯g(isolated hypertriglyceridemia)±wªÌ¡A¥i°§C¨äÁ`Áx©T¾J¡BLDL-Áx©T¾J¡BVLDL-Áx©T¾J¡Bapo B¡BTG¡B¤Î«D-HDL-Áx©T¾J¿@«×¡A¨Ã¼W¥[HDL-Áx©T¾J¿@«×¡C¥Î©ó£]¯×³J¥Õ²§±`¦å¯g(dysbetalipoprotinemia)±wªÌ¡A¥i°§CLDL-Áx©T¾J¿@«×¡C¥»«~¹ï©ó¤ßŦ¦åºÞ¯e¯f¿©¯f²v¤Î¦º¤`²vªº¼vÅT©|¥¼½T¥ß¡C
|
¾AÀ³¯g |
|
°ªÁx©T¾J¦å¯g¡A°ª¤T»Ä¥Ìªoà¦å¯g¡C
|
¥Îªk¥Î¶q |
|
¤@¯ë-¨Ï¥Î¥»«~ªvÀø¤§«e¡A¥²¶·¹Á¸Õ¥Î¾A·íªº¶¼¹±±¨î¡B¹B°Ê¡A¥H¤ÎªÎDªº±wªÌ´î«µ¥¤èªk¡A¨Ó±±¨î°ªÁx©T¾J¦å¯g¡A¨Ã¥BªvÀø¨ä¥L¼ç¦bªº¯e¯f¡C±wªÌ¦batorvastatinªvÀø´Á¶¡¡A¤´¶·±µ¨ü¼Ð·Çªº°Áx©T¾J¶¼¹ªvÀø¡C¾¯¶q½d³ò¬Oatorvastatin 10-80 mg¡A¨C¤éªA¥Î¤@¦¸¡CªAÃĮɶ¡¦±ß¤£©ë¡AÀHÀ\©ÎªÅ¸¡§¡¥i¡C°_©l¾¯¶q©Mºû«ù¾¯¶qÀ³®Ú¾Ú±wªÌLDL-Áx©T¾Jªº°ò¦ȡBªvÀø¥Ø¼Ð»PªvÀø¦¨®ÄÓ§O½Õ¾ã¡C ìµo©Ê°ªÁx©T¾J¦å¯g¤Î²V¦X«¬°ª¯×¦å¯g ¤j¦h¼Æ±wªÌ¥Îatorvastatin 10 mg¨C¤éªA¥Î¤@¦¸ªº¾¯¶q´N±±¨î±o«Ü¦n¡C©úÅ㪺ªvÀø®ÄªG¦b¨â¶g¤§¤º¥X²{¡A¦Ó³Ì¤jªºªvÀø®ÄªG³q±`¦b¥|¶g¤§¤º¥X²{¡C¦bªø´ÁªvÀø´Á¶¡¤´«ùÄò³oºØªvÀø®ÄªG¡C ¦P«¬±µ¦X¤l®a±Ú«¬°ªÁx©T¾J¦å¯g ¤@¶µ°w¹ï¦P«¬±µ¦X¤l®a±Ú«¬°ªÁx©T¾J¦å¯g±wªÌªA¥Î¥»«~ªº®¦·O¨Ï¥Î¬ã¨sÅã¥Ü¡A¤j¦h¼Æ±wªÌ¹ïatorvastatin 80mg¨ã¦³°§CLDLÁx©T¾J¤j©ó15%¥H¤W(18-45%)ªºÀø®Ä¤ÏÀ³¡C ²§«¬±µ¦X¤l®a±Ú«¬°ªÁx©T¾J¦å¯g¨àµ£±wªÌ(10-17·³) «Øij°_©l¾¯¶q¬°10mg/¤é¡A³Ì°ª«Øij¾¯¶q¬°20mg/¤é(¤j©ó20 mgªº¾¯¶q¥¼´¿¦b¦¹±wªÌ¸s¤¤°µ¹L¬ã¨s)¡A¥BÀ³®Ú¾ÚªvÀø¥Ø¼ÐÓ§O½Õ¾ã¾¯¶q¡AÀ³¶¡¹j4¶g©Î§ó¤[°µ¤@¦¸¾¯¶q½Õ¾ã¡C
|
ÃİʤO¾Ç |
|
§l¦¬¡G LIPITOR¤fªA§l¦¬¨³³t¡AªA¥Î«á1-2¤p®É¤º¥i¹F³Ì°ª¦å¼ß¿@«×¡C§l¦¬¶q»PLIPITORªº¾¯¶q¦¨¥¿¤ñ¡CAtorvastatin (쫬ÃÄ)ªºµ´¹ï¥ÍÅé¥i¥Î²v¬ù14%¡A¦Ó¥þ¨ªºHMG-CoAÁÙ쨻¨C§í¨î¬¡©Ê¬ù30%¡C ¤À§G¡G LIPITORªº¥§¡¤À§GÅé¿n¬ù¬°381¤½¤É¡A¦å¼ß³J¥Õ½èµ²¦X²v¡Ù98%¡C ¥NÁ¡G LIPITOR¼sªx¥NÁ¬°¾Fßm°ò¤Î¹ïßm°ò(ortho-and parahydroxylated)l¥Íª«¡A¥H¤Î¦UºØ£]-®ñ¤Æ²£ª«¡C³o¨Ç¾Fßm°ò¤Î¹ïßm°ò¥NÁ²£ª«ªºHMG-CoAÁÙ쨻¨CÅé¥~§í¨î¬¡©Ê»PLIPITOR¬Û·í¡C¦å²G´`Àô¤ºªºHMG-CoAÁÙ쨻¨C§í¨î¬¡©Ê¬ù¦³70%¬O¨Ó¦Û³o¨Ç¬¡©Ê¥NÁ²£ª«¡C ±Æªn¡G LIPITOR¤Î¨ä¥NÁ²£ª«¸g¹L¨xŦ¤Î/©Î¨x¥~¥NÁ¤§«á¡A¥Dn¸g¥ÑÁx¥Ä±Æªn¡A¦ý¦ü¥G¤£·|¶i¦æ¸z¨x¦A´`Àô¡CLIPITOR¦b¤HÅ骺¥§¡¦å¼ß±Æ°£¥b°I´Á¬ù14¤p®É¡A¦ý¦]¦³¬¡©Ê¥NÁ²£ª«¡A¬G¹ïHMG-CoAÁÙ쨻¨Cªº§í¨î¬¡©Ê¥b°I´Áªø¹F20-30¤p®É¡C¤fªA§ëÃÄ«á¡A¥Ñ§¿²G¦^¦¬ªºatorvastatin¾¯¶q¤Ö©ó2%¡C
|
°Æ§@¥Î |
|
¦Ùµh¡B¸¡Âm¡Bäú¤ß¡B¤þÓi»ÄÂàÓiúF¤É°ª¡B¥H¤Î¨xŦ»Ã¯À¤É°ª¡C
|
¥æ¤¬§@¥Î |
|
1. ¦¹ÃþÃĪ«Y»Pcyclosporine, fibric acidl¥Íª«, niacin(nicotinic acid), erythromycin©ÎazoleÃþ§ÜÅðµß¾¯¤@°_¨Ï¥Î¡A·|¼W¥[¦Ù¯fªº¦MÀI©Ê¡C 2. ¨î»Ä¾¯¡G¥»«~Y»PMaalox TC¦P®ÉªA¥Î¡A«h¥»«~ªº¦å¤¤¿@«×°§C¬ù35%¡CµM¦Ó¡ALDL-Ãþ©T¾J´î¤Ö¤£ÅÜ¡C 3. Antipyrine¡G¥Ñ©ó¥»«~¤£·|¼vÅTantipyrineªºÃİʾǡA¬G¹w®Æ¥¦¤£·|»P¸g¥Ñ¬Û¦P²ÓM¦â¯À²§»Ã¯À¥NÁªºÃĪ«µo¥Í¥æ¤¬¤ÏÀ³¡C 4. Colestipol¡G¥»«~Y»Pcolestipol¦P®ÉªA¥Î¡A¥»«~¦å¼ß¿@«×¬ù°§C25%¡CµM¦Ó¡A¤GªÌ¦P®ÉªA¥Îªº°LDL-Áx©T¾JÀø®Ä¡A¤ñ³æ¿WªA¥Îcolestipol©Î¥»«~§ó±j¡C 5. Cimetidine¡G¥»«~»Pcimetidine¦P®ÉªA¥Î¡A¨Ã¤£·|¼vÅT¥»«~¦å¼ß¿@«×¤Î¨ä°LDL-Áx©T¾JªºÀø®Ä¡C 6. ¥»«~Y¦P®É¨Ö¥Î°¯×½¦Ån¡B¬õÄT¨Ö¥Î¡A¥i¯à·|³y¦¨¨x¥\¯à«ü¼Æ¤W¤É¤Î¦å¤¤¦Ù»Ä¿E酶¤W¤É¡C
|
¸T§Ò |
|
1. ¦³¬¡°Ê©Ê¨x¯f¥]¬A¨xŦÂàÓiúF¤£©úì¦]ªº«ùÄò¤W¤É¤§±wªÌ¡C 2. ¹ï¥»ÃÄ¥ô¦ó¦¨¤À¹L±Ó¤§±wªÌ¡C
|
µ¹¥I³W©w |
|
2.6.°¦å¯×ÃĪ« Drugs used for dyslipidemia 2.6.1.¥þ¥Á°·±d«OÀI°¦å¯×ÃĪ«µ¹¥I³W©wªí¡]86/1/1¡B87/4/1¡B87/7/1¡B91/9/1¡B93/9/1¡B97/7/1¡B102/8/1¡^ ¤ß¦åºÞ¯e¯f©Î¿}§¿¯f±wªÌ¡A»PÃĪ«ªvÀø¥i¨Ã¦æ¡A°_©lÃĪ«ªvÀø¦å¯×È¡GTC¡Ù160mg/dL©Î LDL-C¡Ù100mg/dL¡A¦å¯×¥Ø¼ÐÈ¡GTC¡Õ160mg/dL©ÎLDL-C¡Õ100mg/dL¡F2Ó¦MÀI¦]¤l©Î¥H¤W¡Aµ¹ÃÄ«eÀ³¦³3-6Ó¤ë«DÃĪ«ªvÀø¡A°_©lÃĪ«ªvÀø¦å¯×È¡GTC¡Ù200mg/dL©ÎLDL-C¡Ù130mg/dL ¡A¦å¯×¥Ø¼ÐÈ¡GTC¡Õ200mg/dL©ÎLDL-C¡Õ130mg/dL¡F1Ó¦MÀI¦]¤l¡Aµ¹ÃÄ«eÀ³¦³3-6Ó¤ë«DÃĪ«ªvÀø¡A°_©lÃĪ«ªvÀø¦å¯×È¡GTC¡Ù240mg/dL©ÎLDL-C¡Ù160mg/dL¡A¦å¯×¥Ø¼ÐÈ¡GTC¡Õ240mg/dL©ÎLDL-C¡Õ160mg/dL¡F0Ó¦MÀI¦]¤l¡Aµ¹ÃÄ«eÀ³¦³3-6Ó¤ë«DÃĪ«ªvÀø¡A°_©lÃĪ«ªvÀø¦å¯×È¡GLDL-C¡Ù190mg/dL¡A¦å¯×¥Ø¼ÐÈ¡GLDL-C¡Õ190mg/dL¡F ¤Wz³B¤è³W©w¡G²Ä¤@¦~À³¨C3-6Ó¤ë©â¦åÀˬd¤@¦¸¡A²Ä¤G¦~¥H«áÀ³¦Ü¤Ö¨C6-12Ó¤ë©â¦åÀˬd¤@¦¸¡A¦P®É½Ðª`·N°Æ§@¥Î¤§²£¥Í¦p¨x¥\¯à²§±`¡A¾î¯¾¦Ù·»¸Ñ¯g¡C
¤ß¦åºÞ¯e¯f©w¸q¡G (¤@) «aª¬°Ê¯ßµ°ª¬µw¤Æ¯f¤H¡G¤ßµ±µh¯f¤H¡A¦³¤ß¾ÉºÞÃÒ¹ê©Î¯Ê®ñ©Ê¤ß¹q¹ÏÅܤƩÎt²ü©Ê¸ÕÅ綧©Ê¤ÏÀ³ªÌ(ªþÀˬd³ø§i) (¤G) ¯Ê¦å«¬¸£¦åºÞ¯e¯f¯f¤H¥]§t¡G 1.¸£±ð¶ë¡C 2.¼È®É©Ê¸£¯Ê¦å±wªÌ(TIA)¡C¡]¶EÂ_¶·¥Ñ¯«¸g¬ìÂå®v½T¥ß¡^
¦MÀI¦]¤l©w¸q¡G 1.°ª¦åÀ£ 2.¨k©Ê¡Ù45·³¡A¤k©Ê¡Ù55·³©Î°±¸gªÌ 3.¦³¦µo©Ê«a¤ß¯f®a±Ú¥v(¨k©Ê¡Ø55·³¡A¤k©Ê¡Ø65·³) 4.HDL-C<40mg/dL 5.§lµÒ(¦]§lµÒ¦Ó²Å¦X°_¨BªvÀø·Ç«h¤§Ó®×¡AY¥¼§ÙµÒ¦Ón¨DÃĪ«ªvÀø¡AÀ³¥H¦Û¶OªvÀø)¡C
|
ª`·N¨Æ¶µ |
|
ªAÃÄ´Á¶¡¡A½Ð¤Å¦Y¸²µå¬c©Î³Ü§t¸²µå¬c¥Äªº¶¼®Æ¡C
|
¹L¶q³B²z |
|
Atorvastatin¹L¶q¨S¦³¯S©wªºªvÀø¤èªk¡A¥²¶·¨Ì·Ó±wªÌªº¯gª¬¥[¥HªvÀø¡A¥²n®É¥i¨Ï¥Î¤ä«ù©ÊÀøªk¡C¥Ñ©óatorvastatin»P¦å¼ß³J¥Õ½èªºµ²¦X²v«D±`°ª¡A¬G±À´ú¦å²G³zªRµLªk©úÅã¼W¥[atorvastatinªº²M°£²v¡C
|
ÃÄ«~«O¦s¤è¦¡ |
|
½Ð¸m©ó30ºC¤UÀx¦s¡C
|